tiprankstipranks
Advertisement
Advertisement

HK:1541 Stock Latest News

ImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
Company AnnouncementsImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
4h ago
1541
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
PremiumCompany Announcements
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
6d ago
1541
ImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
PremiumCompany Announcements
ImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
9d ago
1541
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
PremiumCompany Announcements
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
28d ago
1541
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
PremiumCompany Announcements
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
2M ago
1541
ImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
PremiumCompany AnnouncementsImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
2M ago
1541
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
Premium
Company Announcements
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
2M ago
1541
ImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
ImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
3M ago
1541
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
PremiumCompany Announcements
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
3M ago
1541
ImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
PremiumCompany Announcements
ImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
4M ago
1541
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
PremiumCompany Announcements
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
4M ago
1541
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
PremiumCompany Announcements
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
5M ago
1541
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
PremiumCompany AnnouncementsImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
5M ago
1541
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
Premium
Company Announcements
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
6M ago
1541
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
Premium
Company Announcements
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
6M ago
1541
ImmuneOnco Redeems and Subscribes to Wealth Management Products
PremiumCompany Announcements
ImmuneOnco Redeems and Subscribes to Wealth Management Products
6M ago
1541
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
PremiumCompany Announcements
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
6M ago
1541
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
PremiumCompany Announcements
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
7M ago
1541
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
PremiumCompany Announcements
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
7M ago
1541
ImmuneOnco Completes HK$345.1 Million H Share Placement
PremiumCompany AnnouncementsImmuneOnco Completes HK$345.1 Million H Share Placement
7M ago
1541
ImmuneOnco Announces HK$350.9 Million H Share Placement
Premium
Company Announcements
ImmuneOnco Announces HK$350.9 Million H Share Placement
8M ago
1541
ImmuneOnco Advances Lung Cancer Treatment with Phase III Trial Application
Premium
Company Announcements
ImmuneOnco Advances Lung Cancer Treatment with Phase III Trial Application
8M ago
1541

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >